1-3 of 3
Joan Korth-Bradley, PharmD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Treatment Regimen with Moroctocog Alfa (AF-CC) on Bleeding Frequency in Pediatric Aged Subjects with Moderately Severe to Severe Hemophilia A

Mark P. Smith, MD FRACP, FRCPA, Jeremy Rupon, MD, Yasser Wali, MD, Hala Remawi, MD, Joan Korth-Bradley, PharmD, PhD, Lynne Smith, MBA, Pablo Rendo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1205.
https://doi.org/10.1182/blood-2018-99-111891
Published: 2018
Journal Articles

Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

Brinda Tammara, PhD, Kelly Ryan, Anna Plotka, Frank E. Shafer, MD, Hua Wei, David Readett, Annie Fang, Joan Korth-Bradley, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1083.
https://doi.org/10.1182/blood-2018-99-111926
Published: 2018
Journal Articles

An Open-Label Study of the Safety and Efficacy of Morotocog Alfa (AF-CC) in Previously Untreated Patients Aged <6 Years in Usual Care Settings

Kaan Kavakli, MD, James Baumann, Francois Pierre Huard, MS, MBA, Lynne Smith, MBA, Christine Alvey, Joan Korth-Bradley, PharmD, PhD, Pablo Rendo, MD, Jeremy Rupon, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1091.
https://doi.org/10.1182/blood.V130.Suppl_1.1091.1091
Published: 2017